Thursday, May 26, 2022
Arabic Arabic Bengali Bengali English English French French Hindi Hindi Indonesian Indonesian Malay Malay Punjabi Punjabi Russian Russian Spanish Spanish Turkish Turkish Urdu Urdu

Indonesia

Intellasia East Asia News – WHO launches traditional medicine hub in India

<!-- --> The World Health Organization launched its Global Centre for Traditional Medicine at a site in India on Tuesday, aimed at unlocking its potential by blending ancient practices with modern science. The GCTM knowledge hub...

Intellasia East Asia News – Moderna seeks FDA authorisation for second COVID booster for all adults

<!-- --> Moderna Inc (MRNA.O) on late Thursday sought emergency use authorisation with US health regulators for a second COVID-19 booster shot for all adults, as a surge in cases in some parts of the world fuels...

Intellasia East Asia News – AstraZeneca sees higher 2022 sales, but COVID boost waning

<!-- --> AstraZeneca (AZN.L) forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday after beating fourth-quarter profit expectations, but warned the boost from its COVID-19 products would fall. ...

Intellasia East Asia News – New COVID-19 infections decrease in the Americas, says regional agency

<!-- --> New COVID-19 infections and hospitalisations are beginning to go down in some countries in the Americas, but deaths continue to rise in parts of Central and South America, the Pan American Health Organisation (PAHO) said...

Intellasia East Asia News – J&J pauses COVID-19 vaccine manufacturing in crucial plant NYT

<!-- --> Johnson & Johnson (JNJ.N) quietly shut down the only plant making usable batches of its COVID-19 vaccine late last year, the New York Times reported, citing people familiar with the decision. The halt is...

Intellasia East Asia News – COVID disrupts health services in over 90pct of countries WHO

<!-- --> Disruptions in basic health services such as vaccination programmes and treatment of diseases like Aids were reported in 92 percent of 129 countries, a World Health Organization survey on the impact of the COVID-19 pandemic...

Intellasia East Asia News – Merck says COVID-19 pill ‘active’ against Omicron

<!-- --> Merck’s anti-Covid pill remains “active” against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies. The oral treatment, called molnupiravir, is taken within five days of symptom onset and...

Intellasia East Asia News – Merck’s COVID-19 pill active against Omicron in lab studies

<!-- --> Merck & Co Inc (MRK.N) and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading Omicron variant. The data evaluated the antiviral...

Intellasia East Asia News – Pfiser, Moderna shots safe during in vitro fertilisation; healthy gut bacteria may help prevent long COVID

<!-- --> The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. mRNA vaccines...

Intellasia East Asia News – Sinovac regimen gets strong boost from Pfiser, AstraZeneca or J&J COVID shots-study

<!-- --> A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfiser-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac’s (SVA.O) CoronaVac shot, a study...
- Advertisement -

Latest News

- Advertisement -